Guardant Health, Inc. (GH)
165.22
+2.23
(+1.37%)
USD |
NASDAQ |
Oct 15, 12:57
Guardant Health EPS Diluted (Quarterly) : -0.9042 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.9042 |
| March 31, 2026 | -0.8538 |
| December 31, 2025 | -0.9987 |
| September 30, 2025 | -0.743 |
| June 30, 2025 | -0.8049 |
| March 31, 2025 | -0.7682 |
| December 31, 2024 | -0.897 |
| September 30, 2024 | -0.8757 |
| June 30, 2024 | -0.8381 |
| March 31, 2024 | -0.9447 |
| December 31, 2023 | -1.578 |
| September 30, 2023 | -0.7313 |
| June 30, 2023 | -0.6688 |
| March 31, 2023 | -1.301 |
| December 31, 2022 | -1.365 |
| September 30, 2022 | -1.584 |
| June 30, 2022 | -2.248 |
| March 31, 2022 | -1.210 |
| December 31, 2021 | -0.8939 |
| Date | Value |
|---|---|
| September 30, 2021 | -1.060 |
| June 30, 2021 | -0.9644 |
| March 31, 2021 | -1.086 |
| December 31, 2020 | -0.9373 |
| September 30, 2020 | -0.7802 |
| June 30, 2020 | -0.5691 |
| March 31, 2020 | -0.2938 |
| December 31, 2019 | -0.2682 |
| September 30, 2019 | -0.1371 |
| June 30, 2019 | -0.1303 |
| March 31, 2019 | -0.3031 |
| December 31, 2018 | -0.2986 |
| September 30, 2018 | -0.2852 |
| June 30, 2018 | -0.2533 |
| March 31, 2018 | -0.162 |
| December 31, 2017 | -0.1763 |
| September 30, 2017 | -0.3346 |
| June 30, 2017 | -0.2757 |
| March 31, 2017 | -0.1875 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Natera, Inc. | -0.4674 |
| Quest Diagnostics, Inc. | 2.848 |
| Labcorp Holdings, Inc. | 3.643 |
| OPKO Health, Inc. | -0.0111 |
| Psychemedics Corp. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -120.14M |
| Revenue (Quarterly) | 334.98M |
| Total Expenses (Quarterly) | 455.12M |
| Enterprise Value | 22.42B |
| Gross Profit Margin (Quarterly) | 65.39% |
| Profit Margin (Quarterly) | -35.87% |
| Earnings Yield | -2.12% |
| Normalized Earnings Yield | -2.072 |